Involvement of lysophosphatidic acid in bone cancer pain by potentiation of TRPV1 via PKCε pathway in dorsal root ganglion neurons

Molecular Pain

Volumn 6, Issue , 2010, Pages

  Pan, Hai Li ^a   Zhang, Yu Qiu ^a   Zhao, Zhi Qi ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CAPSAICIN; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID 1; LYSOPHOSPHATIDIC ACID 1 ANTAGONIST; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR; RHO KINASE INHIBITOR; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; LYSOPHOSPHOLIPID; VANILLOID RECEPTOR; VANILLOID RECEPTOR SUBTYPE 1;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CANCER; BREAST CARCINOMA; CANCER PAIN; CARCINOMA CELL; CELL ISOLATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOSE RESPONSE; EVOKED RESPONSE; FEMALE; HYPERALGESIA; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; RAT; SPINAL GANGLION; UPREGULATION; ANIMAL; BONE TUMOR; DRUG ANTAGONISM; EXPERIMENTAL NEOPLASM; IMMUNOHISTOCHEMISTRY; METABOLISM; NERVE CELL; PAIN; PATHOLOGY;

ANIMALS; BONE NEOPLASMS; GANGLIA, SPINAL; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; LYSOPHOSPHOLIPIDS; NEOPLASMS, EXPERIMENTAL; NEURONS; PAIN; PROTEIN KINASE C-EPSILON; RATS; TRPV CATION CHANNELS;

EID: 78649500338     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-6-85     Document Type: Article

References (67)

1. Thurlimann B, deStoutz ND. Causes and treatment of bone pain of malignant origin. Drugs 1996, 51:383-398. 10.2165/00003495-199651030-00004, 8882377.
2. Peters CM, Ghilardi JR, Keyser CP, Kubota K, Lindsay TH, Luger NM, Mach DB, Schwei MJ, Sevcik MA, Mantyh PW. Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Exp Neurol 2005, 193:85-100. 10.1016/j.expneurol.2004.11.028, 15817267.
3. Anliker B, Chun J. Cell surface receptors in lysophospholipid signaling. Semin Cell Devl Biol 2004, 15:457-465.
4. Fang XJ, Schummer M, Mao ML, Yu SX, Tabassam FH, Swaby R, Hasegawa Y, Tanyi JL, LaPushin R, Eder A, Jaffe R, Erickson J, Mills GB. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. BBA-Mol Cell Biol L 2002, 1582:257-264.
5. Ishdorj G, Graham BA, Hu X, Chen J, Johnston JB, Fang X, Gibson SB. Lysophosphatidic acid (LPA) protected cancer cells from histone deacetylase(HDAC) Inhibitor-induced apoptosis through activation of HDAC. J Biol Chem 2008, 283:16818-16829. 10.1074/jbc.M710177200, 2423270, 18408217.
6. Radeff-Huang J, Seasholtz TM, Matteo RG, Brown JH. G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival. J Cell Biochem 2004, 92:949-966. 10.1002/jcb.20094, 15258918.
7. Guo R, Kasbohm EA, Arora P, Sample CJ, Baban B, Sud N, Sivashanmugam P, Moniri NH, Daaka Y. Expression and function of lysophosphatidic acid LPA(1) receptor in prostate cancer cells. Endocrinology 2006, 147:4883-4892. 10.1210/en.2005-1635, 16809448.
8. Aoki J, Taira A, Takanezawa Y, Kishi Y, Hama K, Kishimoto T, Mizuno K, Saku K, Taguchi R, Arai H. Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 2002, 277:48737-48744. 10.1074/jbc.M206812200, 12354767.
9. Boucharaba A, Serre CM, Gres S, Saulnier-Blache JS, Bordet JC, Guglielmi J, Clezardin P, Peyruchaud O. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest 2004, 114:1714-1725. 535068, 15599396.
10. Eder AM, Sasagawa T, Mao M, Aoki J, Mills GB. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2. Clin Cancer Res 2000, 6:2482-2491.
11. Inoue M, Rashid MH, Fujita R, Contos JJA, Chun J, Ueda H. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med 2004, 10:712-718. 10.1038/nm1060, 15195086.
12. Inoue M, Yamaguchi A, Kawakami M, Chun J, Ueda H. Loss of spinal substance P pain transmission under the condition of LPA1 receptor-mediated neuropathic pain. Mol Pain 2006, 2:25. 10.1186/1744-8069-2-25, 1562366, 16914035.
13. Lee CW, Rivera R, Gardell S, Dubin AE, Chun J. GPR92 as a new G(12/13)- and G(q)-coupled lysophosphatidic acid receptor that increases cAMP, LPA(5). J Biol Chem 2006, 281:23589-23597. 10.1074/jbc.M603670200, 16774927.
14. Noguchi K, Ishii S, Shimizu T. Identification of p2y(9)/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 2003, 278:25600-25606. 10.1074/jbc.M302648200, 12724320.
15. Ahn DK, Lee SY, Han SR, Ju JS, Yang GY, Lee MK, Youn DH, Bae YC. Intratrigeminal ganglionic injection of LPA causes neuropathic pain-like behavior and demyelination in rats. Pain 2009, 146:114-120. 10.1016/j.pain.2009.07.012, 19665300.
16. Fujita R, Kiguchi N, Ueda H. LPA-mediated demyelination in ex vivo culture of dorsal root. Neurochem Int 2007, 50:351-355. 10.1016/j.neuint.2006.09.003, 17056157.
17. Tominaga M, Caterina MJ. Thermosensation and pain. J Neurobiol 2004, 61:3-12. 10.1002/neu.20079, 15362149.
18. Ghilardi JR, Röhrich H, Lindsay TH, Sevcik MA, Schwei MJ, Kubota K, Halvorson KG, Poblete J, Chaplan SR, Dubin AE, Carruthers NI, Swanson D, Kuskowski M, Flores CM, Julius D, Mantyh PW. Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J Neurosci 2005, 25(12):3126-3131. 10.1523/JNEUROSCI.3815-04.2005, 15788769.
19. Honore P, Chandran P, Hernandez G, Gauvin DM, Mikusa JP, Zhong C, Joshi SK, Ghilardi JR, Sevcik MA, Fryer RM, Segreti JA, Banfor PN, Marsh K, Neelands T, Bayburt E, Daanen JF, Gomtsyan A, Lee CH, Kort ME, Reilly RM, Surowy CS, Kym PR, Mantyh PW, Sullivan JP, Jarvis MF, Faltynek CR. Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia. Pain 2009, 142:27-35. 10.1016/j.pain.2008.11.004, 19135797.
20. Menéndez L, Juárez L, García E, García-Suárez O, Hidalgo A, Baamonde A. Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice. Neurosci Lett 2006, 393:70-73. 10.1016/j.neulet.2005.09.046, 16243435.
21. Niiyama Y, Kawamata T, Yamamoto J, Omote K, Namiki A. Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons. Neuroscience 2007, 148:560-572. 10.1016/j.neuroscience.2007.05.049, 17656027.
22. Niiyama Y, Kawamata T, Yamamoto J, Furuse S, Namiki A. SB366791, a TRPV1 antagonist, potentiates analgesic effects of systemic morphine in a murine model of bone cancer pain. Brit J Anaesth 2009, 102(2):251-258. 10.1093/bja/aen347, 19038965.
23. Adcock JJ. TRPV1 receptors in sensitisation of cough and pain reflexes. Pulm Pharmacol Ther 2009, 22:65-70. 10.1016/j.pupt.2008.12.014, 19141328.
24. Numazaki M, Tominaga T, Toyooka H, Tominaga M. Direct phosphorylation of capsaicin receptor VR1 by protein kinase Cepsilon and identification of two target serine residues. J Biol Chem 2002, 277:13375-13378. 10.1074/jbc.C200104200, 11884385.
25. Van der Stelt M, Di Marzo V. Endovanilloids - Putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur J Biochem 2004, 271:1827-1834. 10.1111/j.1432-1033.2004.04081.x, 15128293.
26. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998, 21:531-543. 10.1016/S0896-6273(00)80564-4, 9768840.
27. Zhang H, Cang CL, Kawasaki Y, Liang LL, Zhang YQ, Ji RR, Zhao ZQ. Neurokinin-1 receptor enhances TRPV1 activity in primary sensory neurons via PKCepsilon: a novel pathway for heat hyperalgesia. J Neurosci 2007, 27:12067-12077. 10.1523/JNEUROSCI.0496-07.2007, 17978048.
28. Mao-Ying QL, Zhao J, Dong ZQ, Wang J, Yu J, Yan MF, Zhang YQ, Wu GC, Wang YQ. A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells. Biochem Biophys Res Commun 2006, 345:1292-1298. 10.1016/j.bbrc.2006.04.186, 16725112.
29. Schwei MJ, Honore P, Rogers SD, Salak-Johnson JL, Finke MP, Ramnaraine ML, Clohisy DR, Mantyh PW. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci 1999, 19:10886-10897.
30. Mantyh PW. A mechanism-based understanding of bone cancer pain. Novartis Foundation symposium 2004, 261:194-214. full_text, 15469052.
31. Fukushima N, Chun J. The LPA receptors. Prostag Other Lipid Mediat 2001, 64:21-32.
32. Zhou Y, Li GD, Zhao ZQ. State-dependent phosphorylation of epsilon-isozyme of protein kinase C in adult rat dorsal root ganglia after inflammation and nerve injury. J Neurochem 2003, 85:571-580. 10.1046/j.1471-4159.2003.01675.x, 12694383.
33. Ye X, Inoue H, Ueda H. Botulinum toxin C3 inhibits hyperalgesia in mice with partial sciatic nerve injury. JPN J Pharmacol 2000, 83:161-163. 10.1254/jjp.83.161, 10928331.
34. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389:816-824. 10.1038/39807, 9349813.
35. Nagy I, Santha P, Jancso G, Urban L. The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur J Pharmacol 2004, 500:351-369. 10.1016/j.ejphar.2004.07.037, 15464045.
36. Cesare P, McNaughton P. A novel heat-activated current in nociceptive neurons and its sensitization by bradykinin. Proc Natl Acad Sci USA 1996, 93:15435-15439. 10.1073/pnas.93.26.15435, 26422, 8986829.
37. Ferreira J, da Silva GL, Calixto JB. Contribution of vanilloid receptors to the overt nociception induced by B-2 kinin receptor activation in mice. British Journal of Pharmacology 2004, 141:787-794. 10.1038/sj.bjp.0705546, 1574249, 14967737.
38. Shu X, Mendell LM. Acute sensitization by NGF of the response of small-diameter sensory neurons to capsaicin. J Neurophysiol 2001, 86:2931-2938.
39. Zhang N, Inan S, Cowan A, Sun R, Wang JM, Rogers TJ, Caterina M, Oppenheim JJ. A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. Proc Natl Acad Sci USA 2005, 102:4536-4541. 10.1073/pnas.0406030102, 555471, 15764707.
40. Zhao J, Pan HL, Li TT, Zhang YQ, Zhao ZQ. The sensitization of peripheral C-fibers to lysophosphatidic acid in bone cancer pain. Life Sci 2010, 87:120-125. 10.1016/j.lfs.2010.05.015, 20553953.
41. Ali Z, Ringkamp M, Hartke TV, Chien HF, Flavahan NA, Campbell JN, Meyer RA. Uninjured C-fiber nociceptors develop spontaneous activity and alpha-adrenergic sensitivity following L-6 spinal nerve ligation in monkey. J Neurophysiol 1999, 81:455-466.
42. Djouhri L, Koutsikou S, Fang X, McMullan S, Lawson SN. Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. J Neurosci 2006, 26:1281-1292. 10.1523/JNEUROSCI.3388-05.2006, 16436616.
43. Wu G, Ringkamp M, Hartke TV, Murinson BB, Campbell JN, Griffin JW, Meyer RA. Early onset of spontaneous activity in uninjured C-fiber nociceptors after injury to neighboring nerve fibers. J Neurosci 2001, 21:1-5. RC140.
44. Ma L, Matsumoto M, Xie WJ, Inoue M, Ueda H. Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist. J Neurochem 2009, 109:603-610. 10.1111/j.1471-4159.2009.05987.x, 19222705.
45. Ma L, Uchida H, Nagai J, Inoue M, Chun J, Aoki J, Ueda H. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain. Mol Pain 2009, 5:64. 10.1186/1744-8069-5-64, 2780384, 19912636.
46. Elmes SJ, Millns PJ, Smart D, Kendall DA, Chapman V. Evidence for biological effects of exogenous LPA on rat primary afferent and spinal cord neurons. Brain Res 2004, 1022:205-213. 10.1016/j.brainres.2004.07.005, 15353230.
47. Obreja O, Rathee PK, Lips KS, Distler C, Kress M. IL-10 potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C. Faseb Journal 2002, 16:1497-1503. 10.1096/fj.02-0101com, 12374772.
48. Sugiura T, Tominaga M, Katsuya H, Mizumura K. Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1. J Neurophysiol 2002, 88:544-548.
49. Amadesi S, Nie JJ, Vergnolle N, Cottrell GS, Grady EF, Trevisani M Manni C, Geppetti P, McRoberts JA, Ennes H, Davis B, Mayer EA, Bunnett NW. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci 2004, 24:4300-4312. 10.1523/JNEUROSCI.5679-03.2004, 15128844.
50. Carlton SA, Zhou ST, Du JH, Hargett GL, Ji GC, Coggeshall RE. Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel. Pain 2004, 110:616-627. 10.1016/j.pain.2004.04.042, 15288402.
51. Dai Y, Moriyama T, Higashi T, Togashi K, Kobayashi K, Yamanaka H, Tominaga M, Noguchi K. Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J Neurosci 2004, 24:4293-4299. 10.1523/JNEUROSCI.0454-04.2004, 15128843.
52. Cesare P, Dekker LV, Sardini A, Parker PJ, McNaughton PA. Specific involvement of PKC-epsilon in sensitization of the neuronal response to painful heat. Neuron 1999, 23:617-624. 10.1016/S0896-6273(00)80813-2, 10433272.
53. Zhou Y, Zhou ZS, Zhao ZQ. PKC regulates capsaicin-induced currents of dorsal root ganglion neurons in rats. Neuropharmacology 2001, 41:601-608. 10.1016/S0028-3908(01)00106-X, 11587715.
54. Bhave G, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau R. cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 2002, 35:721-731. 10.1016/S0896-6273(02)00802-4, 12194871.
55. Moriyama T, Higashi T, Togashi K, Iida T, Segi E, Sugimoto Y, Tominaga T, Narumiya S, Tominaga M. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol Pain 2005, 1:3. 10.1186/1744-8069-1-3, 1074353, 15813989.
56. Hucho TB, Dina OA, Levine JD. Epac mediates a cAMP-to-PKC signaling in inflammatory pain: an isolectin B4(+) neuron-specific mechanism. J Neurosci 2005, 25:6119-6126. 10.1523/JNEUROSCI.0285-05.2005, 15987941.
57. Rathee PK, Distler C, Obreja O, Neuhuber W, Wang GK, Wang SY, Nau C, Kress M. PKA/AKAP/VR-1 module: A common link of G(s)-mediated signaling to thermal hyperalgesia. J Neurosci 2002, 22:4740-4745.
58. Hu TH, Exton JH. Mechanisms of regulation of phospholipase D1 by protein kinase Ca. J Bioll Chem 2003, 278:2348-2355.
59. Lee WS, Hong MP, Kim TH, Shin YK, Lee CS, Park M, Song JH. Effects of lysophosphatidic acid on sodium currents in rat dorsal root ganglion neurons. Brain Res 2005, 1035:100-104. 10.1016/j.brainres.2004.12.026, 15713282.
60. Renback K, Inoue M, Ueda H. Lysophosphatidic acid-induced, pertussis toxin-sensitive nociception through a substance P release from peripheral nerve endings in mice. Neurosci Lett 1999, 270:59-61. 10.1016/S0304-3940(99)00464-4, 10454146.
61. Cang CL, Zhang H, Zhang YQ, Zhao ZQ. PKCepsilon-dependent potentiation of TTX-resistant Nav1.8 current by neurokinin-1 receptor activation in rat dorsal root ganglion neurons. Mol Pain 2009, 5:33. 10.1186/1744-8069-5-33, 2715383, 19563686.
62. Fukushima N, Ishii I, Contos JJA, Weiner JA, Chun J. Lysophospholipid receptors. Annu Rev Pharmacol Toxicol 2001, 41:507-534. 10.1146/annurev.pharmtox.41.1.507, 11264467.
63. Kluk MJ, Hla T. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. BBA-Mol Cell Biol L 2002, 1582:72-80.
64. Siehler S, Manning DR. Pathways of transduction engaged by sphingosine 1-phosphate through G protein-coupled receptors. BBA-Mol Cell Biol L 2002, 1582:94-99.
65. Panupinthu N, Zhao L, Possmayer F, Ke HZ, Sims SM, Dixon SJ. P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid. J Biol Chem 2007, 282:3403-3412. 10.1074/jbc.M605620200, 17135244.
66. Xu JJ, Walla BC, Diaz MF, Fuller GN, Gutstein HB. Intermittent lumbar puncture in rats: A novel method for the experimental study of opioid tolerance. Anesth Analg 2006, 103:714-720. 10.1213/01.ane.0000226100.46866.ea, 16931686.
67. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A New and Sensitive Method for Measuring Thermal Nociception in Cutaneous Hyperalgesia. Pain 1988, 32:77-88.l. 10.1016/0304-3959(88)90026-7, 3340425.